亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

Improving Outcome after Respiratory Infection: Novel Microbiome Therapeutic

详细技术说明
Description: Researchat Kansas State University has discovered a novel approach for improvingresponse to respiratory pathogens through modulating the gut microbiome.  The microbiome is defined as the collectionof microorganisms in the gastrointestinal tact (GI) that are critical for the developmentof immunity and digestion of nutrients.  It is well known that probiotics can help alleviateGI issues in humans and animals. However, our research has shown that modulating the microbiome of animals prior to challenge withrespiratory pathogens reduces morbidity and mortality associated withinfection.  This pioneering research at K-State is the first tomake the connection between a healthy & diverse gut microbiome incommercial pigs and enhanced immunity against the most significant and costly respiratory diseases of swine.Porcine reproductive and respiratory syndrome virus(PRRSV) and porcine circovirus type 2 (PCV2) are two of the most importantpathogens affecting the swine industry, decreasing production and animalwelfare due to respiratory disease and reduced growth performance.  In a co-infection model using PRRSV and PCV2,we showed that high-health conventional nursery pigs administered a microbiome therapeuticat weaning had significantly higher survival (Fig), reduced clinical disease, anddecreased virus replication when compared to controls.Advantages: ·        Enhancing immunity against respiratory pathogens·        Natural alternative to antibioticsApplications:  ·        Potential new product category·        Adjuvant to standard vaccination practices·        Prevention of disease caused by respiratorypathogens·        Improved response after exposure to respiratorypathogensPatent Status:  Provisional Patent application filed in May 2017.Interested parties should contact:Kansas State University Institute for Commercialization (KSU-IC)2005 Research Park Circle Manhattan, KS 66502Tel: 785-532-3900 Fax: 785-532-3909E-Mail: ic@k-state.edu
*Abstract
None
国家/地区
美国

欲了解更多信息,请点击 这里
移动设备